Viewing Study NCT00001495


Ignite Creation Date: 2025-12-24 @ 1:37 PM
Ignite Modification Date: 2026-02-21 @ 4:08 PM
Study NCT ID: NCT00001495
Status: COMPLETED
Last Update Posted: 2008-03-04
First Post: 1999-11-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid Tumors
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Camptothecin View
None Cancer View
None Chemotherapy View
None Natural Products View
None Neoplasms View